The Antibody Engine With Abpro's Chan Brothers
Business Of Biotech
00:00
Cell-Strion's Partnership With Cell-Drion Accelerates Development
The ABP 102 approach has been getting some attention in the form of, as I mentioned, a pretty great big giant deal with cells around that. So, cell-strion came about through one of our board members who was actually based over in Korea. They have integrated capabilities all the way from preclinical, manufacturing, all the way to commercialization. And also recently, they've been getting approvals in other areas as well. That really accelerates the development of the molecule.
Transcript
Play full episode
